Elevated IREB2 expression correlated with accelerated lung‐function decline in COPD but predicted improved prognosis in lung cancer B cells, whereas higher CD27+ B cell levels in COPD were associated with protumorigenic activity. The gene discussed is IREB2; the disease is lung carcinoma.